Form 4 for EQH Equitable Holdings, Inc.
Accepted 2024-11-18 00:00:00 ET · period of report 2024-11-15 · accession 0000950170-24-128092 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DT | 2024-11-18 | 2024-11-15 | EQH | Pearson Mark | Pres, CEO, Dir | M - OptEx | $21.34 | +20.0K | 678.6K | +3% | +$426.8K |
| DMT | 2024-11-18 | 2024-11-15 | EQH | Pearson Mark | Pres, CEO, Dir | S - Sale+OE | $47.43 | -30.0K | 648.6K | -4% | -$1.42M |
| DT | 2024-11-18 | 2024-11-15 | EQH | Pearson Mark | Pres, CEO, Dir | M - OptEx | $0.00 | -20.0K | 486.4K | -4% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-11-15 | M | A | 20,000 | $21.34 | 678,554.53 | D | — | — | (F1) The sales reported and options exercised on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 30, 2024. (F2) Includes Restricted Stock Units. |
| 2 | Common | Common Stock | 2024-11-15 | S | D | 20,000 | $47.43 | 658,554.53 | D | — | — | (F1) The sales reported and options exercised on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 30, 2024. (F3) This transaction was executed in multiple trades at prices ranging from $47.1300 to $48.0000. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. (F2) Includes Restricted Stock Units. |
| 3 | Common | Common Stock | 2024-11-15 | S | D | 10,000 | $47.43 | 648,554.53 | D | — | — | (F1) The sales reported and options exercised on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 30, 2024. (F4) This transaction was executed in multiple trades at prices ranging from $47.1500 to $47.9300. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. (F2) Includes Restricted Stock Units. |
| 4 | Derivative | Employee Stock Option (right to buy) | 2024-11-15 | M | D | 20,000 | $0.00 | 486,400 | D | $21.34 · — to 2028-03-01 | 20,000 Common Stock | (F1) The sales reported and options exercised on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 30, 2024. (F5) Grant of employee stock option under the Issuer's 2019 Omnibus Incentive Plan exempt under Rule 16b-3. The options vested in three installments beginning on March 1, 2019. |